Yantai Dongcheng Pharmaceutical Group Co.,Ltd. 002675.SZ Stock
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Price Chart
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. 002675.SZ Financial and Trading Overview
Contents
- Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Price Chart
- Yantai Dongcheng Pharmaceutical Group Co.,Ltd. 002675.SZ Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
- Q&A For Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Stock
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. stock price | 13.13 CNY |
Previous Close | 14.43 CNY |
Open | 14.42 CNY |
Bid | 14.17 CNY x 0 |
Ask | 14.18 CNY x 0 |
Day's Range | 14.15 - 14.5 CNY |
52 Week Range | 11.69 - 20.08 CNY |
Volume | 5.66M CNY |
Avg. Volume | 8.48M CNY |
Market Cap | 11.68B CNY |
Beta (5Y Monthly) | 0.479452 |
PE Ratio (TTM) | 38.2973 |
EPS (TTM) | 0.32 CNY |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | June 9, 2022 |
1y Target Est | 20.95 CNY |
002675.SZ Valuation Measures
Enterprise Value | 12.29B CNY |
Trailing P/E | 38.2973 |
Forward P/E | 22.85484 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 3.2879705 |
Price/Book (mrq) | 2.4376397 |
Enterprise Value/Revenue | 3.459 |
Enterprise Value/EBITDA | 18.497 |
Trading Information
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Stock Price History
Beta (5Y Monthly) | 0.479452 |
52-Week Change | 19.05% |
S&P500 52-Week Change | 20.43% |
52 Week High | 20.08 CNY |
52 Week Low | 11.69 CNY |
50-Day Moving Average | 15.58 CNY |
200-Day Moving Average | 16.38 CNY |
002675.SZ Share Statistics
Avg. Volume (3 month) | 8.48M CNY |
Avg. Daily Volume (10-Days) | 5.77M CNY |
Shares Outstanding | 824.6M |
Float | 539.64M |
Short Ratio | N/A |
% Held by Insiders | 37.60% |
% Held by Institutions | 11.95% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.15 |
Trailing Annual Dividend Yield | 1.03% |
5 Year Average Dividend Yield | 92.00% |
Payout Ratio | 0.4025 |
Last Split Factor | 30:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 8.51% |
Operating Margin (ttm) | 15.31% |
Gross Margin | 45.05% |
EBITDA Margin | 18.69% |
Management Effectiveness
Return on Assets (ttm) | 4.23% |
Return on Equity (ttm) | 6.70% |
Income Statement
Revenue (ttm) | 3.55B CNY |
Revenue Per Share (ttm) | 4.37 CNY |
Quarterly Revenue Growth (yoy) | -3.30% |
Gross Profit (ttm) | 1.54B CNY |
EBITDA | 664.48M CNY |
Net Income Avi to Common (ttm) | 302.47M CNY |
Diluted EPS (ttm) | 0.37 |
Quarterly Earnings Growth (yoy) | -8.79% |
Balance Sheet
Total Cash (mrq) | 937.13M CNY |
Total Cash Per Share (mrq) | 1.14 CNY |
Total Debt (mrq) | 751.04M CNY |
Total Debt/Equity (mrq) | 14.05 CNY |
Current Ratio (mrq) | 1.32 |
Book Value Per Share (mrq) | 5.813 |
Cash Flow Statement
Operating Cash Flow (ttm) | 852.95M CNY |
Levered Free Cash Flow (ttm) | 20.21M CNY |
Profile of Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
Country | China |
State | N/A |
City | Yantai |
Address | No.7 ChangBaiShan Road |
ZIP | 264006 |
Phone | 86 53 5639 1521 |
Website | https://www.dcb-group.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 2174 |
Yantai Dongcheng Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the manufacture and sale of biochemical APIs, finished dosage forms, nuclide drugs, and healthy products for cardiovascular, antitumor, urology, orthopedics, and other therapeutic areas. It offers heparin, chondroitin sulphate sodium and calcium, and glucosamine series products, as well as collagen, hyaluronic acid, and cytochrome C. The company also provides nadroparin calcium, hydrocortisone sodium succinate, chorionic gonadotrophin, and menotropins for injection, as well as ambroxol hydrochloride dispersible tablets, jinjunling capsule, metformin hydrochloride and glibenclamide tablets, clemastine fumarate tablets, and wind dispelling itch relieving granule. In addition, it offers Technetium [99Tc] Methylene Diphosphonate Injection; Technetium [99mTc] Tc labeled tracers; 2-[18F]FDG that helps to detect the activity of tumor cells; sodium iodide [131I] oral solution; iodine [125I] seed use to treat internal radiation of various malignant tumors; [14C]Urea capsule; and jiabaolin glucosamine chondroitin sulfate capsule. The company also exports its products to approximately 40 countries and regions, including the Europe, America, Asia Pacific, and internationally. Yantai Dongcheng Pharmaceutical Group Co.,Ltd. was founded in 1998 and is based in Yantai, China.
Q&A For Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Stock
What is a current 002675.SZ stock price?
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. 002675.SZ stock price today per share is 13.13 CNY.
How to purchase Yantai Dongcheng Pharmaceutical Group Co.,Ltd. stock?
You can buy 002675.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Yantai Dongcheng Pharmaceutical Group Co.,Ltd.?
The stock symbol or ticker of Yantai Dongcheng Pharmaceutical Group Co.,Ltd. is 002675.SZ.
Which industry does the Yantai Dongcheng Pharmaceutical Group Co.,Ltd. company belong to?
The Yantai Dongcheng Pharmaceutical Group Co.,Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Yantai Dongcheng Pharmaceutical Group Co.,Ltd. have in circulation?
The max supply of Yantai Dongcheng Pharmaceutical Group Co.,Ltd. shares is 824.6M.
What is Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Price to Earnings Ratio (PE Ratio)?
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. PE Ratio is 41.03125000 now.
What was Yantai Dongcheng Pharmaceutical Group Co.,Ltd. earnings per share over the trailing 12 months (TTM)?
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. EPS is 0.32 CNY over the trailing 12 months.
Which sector does the Yantai Dongcheng Pharmaceutical Group Co.,Ltd. company belong to?
The Yantai Dongcheng Pharmaceutical Group Co.,Ltd. sector is Healthcare.